MAZE in the 13F filings
Maze Therapeutics Inc · CUSIP 578784100
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 1 listed it in both
- Shares listed
- 7,234,149
- combined, among listed positions
- Reported value
- $300m
- combined, at the quarter end
Among the 92 comparable managers: 15 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,107,804.
Managers listing MAZE in Q4 2025
22 of 22 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 3,142,587 shares now+2,390,713
- Citadel Advisors LLCnew position · 448,217 shares now+448,217
- Millennium Management LLCnew position · 154,470 shares now+154,470
- Freestone Grove Partners LPnew position · 118,876 shares now+118,876
- T. Rowe Price Associates Incexisting position · 115,711 shares now+105,237
Reductions
- Balyasny Asset Management LLCexisting position · 199,212 shares now-234,513
- Schonfeld Strategic Advisors LLCexisting position · 48,200 shares now-65,849
- Renaissance Technologies LLCexisting position · 27,100 shares now-59,000
- AllianceBernstein LPexisting position · 33,220 shares now-26,880
- Two Sigma Investments LPexisting position · 7,245 shares now-3,905
New positions and exits
New (10)
Exited (2)
- Susquehanna International Group LLPwas $419k
- Winton Group Ltdwas $376k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2025 | 2 | $10m | 2 | 0 |
| Q2 2025 | 1 | $12m | 1 | 1 |
| Q3 2025 | 1 | $27m | 1 | 0 |
| Q4 2025 | 4 | $213m | 15 | 8 |
| Q1 2026 | 5 | $127m | 15 | 12 |
| Q2 2026 | 5 | $170m | 14 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MAZE and GILD →MAZE and AMGN →MAZE and ARGX →Choose a stock to compare with MAZE →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MAZE, latest filings →Back to the 13F Explorer →